INTRODUCTION AND OBJECTIVES: Laparoscopic Radical Nephrectomy (RN) is the current standard of care for large organ confined renal tumors while Partial Nephrectomy (PN) is recommanded for tumor sizes up to 7 cm. PN preserves long term renal function with possible effect on overall survival. Axitinib, a potent VEGFR TKI can reduce the size of primary tumor in metastatic setting. Our primary objective was to test the ability of axitinib to reduce the size of large tumors for shifting from a RN to a PN indication.
INTRODUCTION AND OBJECTIVES: Laparoscopic Radical
Nephrectomy (RN) is the current standard of care for large organ confined renal tumors while Partial Nephrectomy (PN) is recommanded for tumor sizes up to 7 cm. PN preserves long term renal function with possible effect on overall survival. Axitinib, a potent VEGFR TKI can reduce the size of primary tumor in metastatic setting. Our primary objective was to test the ability of axitinib to reduce the size of large tumors for shifting from a RN to a PN indication.
METHODS: Patients with localized (cT2N0M0) RCCs were enrolled in a prospective phase II trial assessing the effect of neoadjuvant axitinib prior to surgery (PN or RN). Main inclusion criteria were: age 18, histologically proven clear cell RCC, MDRD creatinin clearance 60 ml/min, cT2a N0NxM0 tumors (&[null]> 7cm; 10 cm). Medical treatment consisted in axitinib 5 mg up to 10 mg tw/d during 2 to 6 months prior surgery according to radiological response.
RESULTS: A total of 18 patients including 11 men (61%) and 7 women (39%) with a median age of 60 yrs were enrolled. Median baseline tumor size, RENAL score, serum creatinine and MDRD estimated GFR were: 7.6 cm, 11, 0.8 mg/dl and 96.5 ml/min respectively. Duration of treatment was 2, 4 and 6 months in 12 (66%), 3 (17%) and 3 cases (17%), respectively. Median interval from treatment stop to surgery was 6 days. After neoadjuvant treatment median tumor size and RENAL score decreased to 6.2 cm and 10. 89% of patients presented a decrease in maximum tumor diameter, with median size reduction of 19%. Out of the 17 patients who were operated, 16 (94%) underwent a PN (9 robotic & 7 open), including 67% of the cases which were performed for tumors 7cm. At 1 month from surgery, median serum creatinin and MDRD estimated GFR were 0.9 mg/dl and 87 ml/min, respectively. Medical and surgical complications included 1 embolization for severe bleeding and 1 Clavien V complication at 1 month after surgery due to massive myocardial infarction.
CONCLUSIONS: Neoadjuvant axitinib in cT2 renal tumors allowed cT1 downstaging and nephron sparing surgery in almost 70% of the cases. However, PN procedures remained high complexity cases requiring adequate surgeon expertise and information of the patients for possible morbidity of these procedures.
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MP72-20 DIFFERENTIAL HEMODYNAMIC AND ANTIHYPERTENSIVE CHANGES AFTER PARTIAL NEPHRECTOMY VERSUS RADICAL NEPHRECTOMY
Ryan Hutchinson*, Nirmish Singla, Laura-Maria Krabbe, Solomon Woldu, Gong Chen, Charles Rew, Isamu Tachibana, Yair Lotan, Jeffrey A. Cadeddu, Vitaly Margulis, Dallas, TX INTRODUCTION AND OBJECTIVES: Partial nephrectomy is a common therapy for small renal masses and is associated with improved postoperative renal function when compared to radical nephrectomy. The highest quality prospective study of partial versus radical nephrectomy demonstrated worse overall survival in patients undergoing partial nephrectomy which appeared to be driven by cardiovascular outcomes. We examined patients undergoing partial and radical nephrectomy to assess for possible differential postsurgical hemodynamic effects.
METHODS: An institutional renal mass database was queried for patients undergoing partial or radical nephrectomy between 2006 and 2012. Serial blood pressure followup, clinicopathologic variables and changes in medications including antihypertensives were collected. Patients were excluded for inadequate data, non-curative-intent surgery, non-cancer surgical indication and absence of medication information. Time-dependent changes in blood pressure were compared by split-plot ANOVA and addition or modification of antihypertensive regimen were studied as time-to-event survival analyses with Kaplan-Meier curves and a Cox proportional hazards model. RESULTS: Between 2006 and 2012, 402 partial nephrectomies and 205 radical nephrectomies were performed and a final cohort of 264 partial nephrectomy and 130 radical nephrectomy cases was identified with evaluable data. Patients undergoing partial nephrectomy were significantly younger, more likely to have T1 tumors, and had lower preoperative creatinine values (p < 0.001 for all). No differences were noted on postoperative systolic blood pressures, diastolic blood pressures and heart rates (p > 0.05) however, these analyses were underpowered on post-hoc analysis. Significantly more patients who underwent partial nephrectomy started new antihypertensive medications postoperatively (p ¼ <0.001) and surgical treatment remained as a significant independent predictor on multivariate Cox regression (HR 2.51, p ¼ 0.002).
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